From Bench to Fireside

From Bench to Fireside™ is a podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients.

From Bench to Fireside is a science podcast hosted by Parker Institute for Cancer Immunotherapy, with 15 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Parker Institute for Cancer Immunotherapy hosts From Bench to Fireside, a science show with 15 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #5

  From Biological Limits to Intelligent Immunity with Kole Roybal, PhD

  Apr 17, 202549 minS2

  <p>What if our immune cells could be reprogrammed to sense, decide and act—outsmarting even the most elusive tumors?</p><p>In this episode of From Bench to Fireside Kole Roybal, PhD, Director of the Parker Institute of Cancer Immunotherapy Center at UCSF, joins PICI Chief Scientific Officer John Connolly, PhD, to break down how engineered immune cells are moving from the lab to the clinic—and changing how we approach solid tumors. They discuss how technologies like SynNotch and SNIPR are giving immune cells programmable intelligence—and how PICI’s collaborative model helped accelerate these innovations from discovery to patie...

  ListenShow Notes
• 

  Episode #4

  From Cancer’s Hidden Metabolic Tricks to Breakthrough Discoveries That Overcome Them with Roberta Zappasodi, PhD

  Mar 10, 202540 minS2

  <p>In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Roberta Zappasodi, PhD, Assistant Professor of Hematology and Medical Oncology and member of the PICI Center at Weill Cornell Medicine.</p><p>Dr. Zappasodi has been instrumental in uncovering immunotherapy resistance -- from her early career preparing vaccines from tumor samples, to her current, cutting-edge research on how tumor environments impact treatment. Together, they explore her discoveries on the relationship between tumor glycolytic states and vasculature, the importance of T-cell trafficking, and the transformative potential...

  ListenShow Notes
• 

  Episode #4

  From Cancer’s Hidden Metabolic Tricks to Innovative Discoveries That Overcome Them with Roberta Zappasodi, PhD

  Mar 10, 202540 minS2

  <p>In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Roberta Zappasodi, PhD, Assistant Professor of Hematology and Medical Oncology and member of the PICI Center at Weill Cornell Medicine.</p><p>Dr. Zappasodi has been instrumental in uncovering immunotherapy resistance -- from her early career preparing vaccines from tumor samples, to her current, cutting-edge research on how tumor environments impact treatment. Together, they explore her discoveries on the relationship between tumor glycolytic states and vasculature, the importance of T-cell trafficking, and the transformative potential...

  ListenShow Notes
• 

  Episode #3

  From Metastatic Melanoma to Immune Engineering with Antoni Ribas, MD, PhD

  Feb 24, 202539 minS2

  <p>In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Antoni Ribas, MD, PhD, Director of the PICI Center at UCLA, professor of medicine at the David Geffen School of Medicine at UCLA and Director of the Tumor Immunology Program at the UCLA Health Jonsson Comprehensive Cancer Center.</p><p>Dr. Ribas, who led one of the largest phase 1 clinical oncology trial to date, has been instrumental in advancing our understanding of immune checkpoint inhibitors and cellular therapies. Together, they explore Dr. Ribas' journey from...

  ListenShow Notes
• 

  Episode #2

  From the Front Lines to the Frontiers of Defeating Breast Cancer with Elizabeth Mittendorf, MD, PhD

  Feb 10, 202540 minS2

  <p>In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Elizabeth Mittendorf, MD, PhD, MHCM, FASCO - Director of the Breast Immuno-Oncology Program and Co-Director of the PICI Center at Dana-Farber Cancer Institute, Robert and Karen Hale Distinguished Chair in Surgical Oncology and the Director of the Breast Immuno-Oncology Program at Brigham and Women’s Hospital, and the 2026-2027 incoming President for the American Society for Clinical Oncology (ASCO). A leading expert in cancer immunotherapy, Dr. Mittendorf’s groundbreaking research has advanced the role of vacc...

  ListenShow Notes

Recent guests on From Bench to Fireside. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.